Overview
John Hainsworth is an Oncologist in Nashville, Tennessee. Dr. Hainsworth is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Basal Cell Skin Cancer, Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, Lung Cancer, and Orchiectomy. Dr. Hainsworth is currently accepting new patients.
His clinical research consists of co-authoring 151 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Vanderbilt Health Clinicians, LLC
Brian Rini is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Rini is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Prostatectomy. Dr. Rini is currently accepting new patients.
Nancy Davis is an Oncologist in Nashville, Tennessee. Dr. Davis is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Adult Soft Tissue Sarcoma, WT1-Related Wilms Tumor Syndromes, and Liver Embolization. Dr. Davis is currently accepting new patients.
Tennessee Oncology PLLC
Kathryn Beckermann is a Hematologist Oncology specialist and a Hematologist in Franklin, Tennessee. Dr. Beckermann is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Adult Soft Tissue Sarcoma. Dr. Beckermann is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Basal Cell Skin CancerDr. Hainsworth isDistinguished. Learn about Basal Cell Skin Cancer.
- Advanced
- Breast CancerDr. Hainsworth isAdvanced. Learn about Breast Cancer.
- Follicular LymphomaDr. Hainsworth isAdvanced. Learn about Follicular Lymphoma.
- Lung CancerDr. Hainsworth isAdvanced. Learn about Lung Cancer.
- Neuroendocrine TumorDr. Hainsworth isAdvanced. Learn about Neuroendocrine Tumor.
- Non-Hodgkin LymphomaDr. Hainsworth isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Hainsworth isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- AgranulocytosisDr. Hainsworth isExperienced. Learn about Agranulocytosis.
- AstrocytomaDr. Hainsworth isExperienced. Learn about Astrocytoma.
- B-Cell LymphomaDr. Hainsworth isExperienced. Learn about B-Cell Lymphoma.
- Carcinoid SyndromeDr. Hainsworth isExperienced. Learn about Carcinoid Syndrome.
- Chronic B-Cell Leukemia (CBCL)Dr. Hainsworth isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Hainsworth isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).